15 MIN DELAY
Latest Share Price
Latest NewsPress Releases Regulatory News
About our products
No company endeavours to do more to help interventional specialists in their quest to see more, reach further and treat smarter.
Our pharmaceuticals portfolio offers antidotes that alleviate acute toxicities.
Named Patient Supplies
Under strict regulations, we are permitted to allow healthcare professionals access to certain products still in the pre-approval phase.
BTG’s success stems from the hard work and contributions of our people. As we grow, we need people who share our values and exhibit the behaviors that make working here different.Careers
10 Apr 2018
If immuno-oncology is going to be a silver bullet, we may need help with the aim.
BTG is partnering with the Society of Interventional Oncology to support a multidisciplinary approach to turn the body’s immune system into a cancer-fighting weapon.Read more
05 Oct 2017
BTG plc acquires Roxwood Medical
BTG expands its Interventional Vascular business with the acquisition of Roxwood Medical, an innovative provider of advanced cardiovascular specialty catheters.Read more
Innovation is a continuous process at BTG that starts with the needs of patients and an in-depth knowledge of our customers.Innovation
13 Jun 2017
BTG plc Annual Report and Accounts 2017
See more. Reach further. Treat smarter.Read the report here
BTG Ranks 5th in Global Gender Equality Index
When compiling the list of The Top 200 Companies, Equileap collaborated with index provider, Solactive, to consider 19 gender equality criteria such as leadership, career development, work-life balance, equal pay, family leave, as well as health & safety.Find out more
We are committed to ensuring that we provide full, accurate, balanced and timely information to the medical professionals who prescribe our products.Healthcare Professionals
We don’t compromise with the truth, ethics or integrity – we foster a culture of responsibility and high standards across the company.Responsibility